• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Difficult to Insert (1316); Difficult to Remove (1528); Device Dislodged or Dislocated (2923)
Patient Problems Pain (1994); Uterine Perforation (2121)
Event Type  Injury  
Event Description
This spontaneous case was reported by a physician and describes the occurrence of uterine perforation ("they found multiple perforations") and device dislocation ("one coil suspected of being located in the mesentery of the colon") in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.Medical conditions: no known history of pelvic pain before any of the essure placements.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced uterine perforation (seriousness criteria medically significant and intervention required), device dislocation (seriousness criteria medically significant and intervention required), procedural pain ("had three previous failed attempts at essure placement who complained of pain"), complication of device insertion ("had three previous failed attempts at essure placement who complained of pain") and complication of device removal ("one remaining coil suspected of being located in the mesentery of the colon, plans to remove remaining coil").The patient was treated with surgery (underwent a hysterectomy) and surgery (md plans to remove remaining coil).At the time of the report, the uterine perforation, procedural pain, complication of device insertion and complication of device removal outcome was unknown.The reporter provided no causality assessment for complication of device insertion, complication of device removal, device dislocation, procedural pain and uterine perforation with essure.Diagnostic results (normal ranges are provided in parenthesis if available): x-ray - on an unknown date: several perforations in various locations.Post-op she was found on x-ray to have one remaining coil suspected of being located in the mesentery of the colon.Company causality comment: no lot number or sample available for investigation.There is no evidence that a device related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k. shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981-0915
MDR Report Key6684208
MDR Text Key78985803
Report Number2951250-2017-02430
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Reporter Occupation Other
Type of Report Initial
Report Date 07/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Date Manufacturer Received06/16/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-